推进阿尔茨海默病和相关痴呆症患者的远程监测:系统性审查
Mohmmad Arif Shaik1, Fahim Islam Anik2, Md Mehedi Hasan1
1Department of Electrical and Computer Engineering, Kennesaw State University, Kennesaw, GA, United States.
JMIR aging
|May 14, 2025
概括
远程监控技术在阿尔茨海默病 (AD) 护理方面表现有前途,提高了患者的安全性,减少了护理人员的压力. 然而,目前的研究需要更好地解决患者需求,隐私和技术设计中的可用性.
科学领域:
- 老年学是一门学科.
- 生物医学工程 生物医学工程
- 医疗信息学 医疗信息学
背景情况:
- 远程监控技术为阿尔茨海默病 (AD) 护理提供了新的途径,旨在减少护理人员的负担并改善患者的生活质量.
- 可穿戴设备,环境传感器和智能家居系统将技术与医疗保健相结合,以提高患者安全性和实时健康监测.
研究的目的:
- 评估遥感技术在改善阿尔茨海默病患者治疗结果方面的有效性.
- 确定减轻医疗保健专业人员和护理人员负担的策略.
- 提出针对AD和相关痴呆症的综合远程监控框架,考虑监管合规性,以用户为中心的设计和隐私.
主要方法:
- 根据PRISMA框架进行的系统审查.
- 在四个主要的电子数据库中进行了搜索 (谷歌学者,PubMed,IEEE Xplore,DBLP).
- 搜索于2024年2月20日进行,并于2024年5月18日更新.
主要成果:
- 31个出版物满足了纳入标准,重点关注AD护理的技术,实用性,安全性和设计.
- 研究强调数据收集 (行为,生理,环境),但缺乏对患者/护理人员需求,隐私和可用性的评估.
- 许多研究缺乏强有力的标准和批判性评估,表明需要综合框架.
结论:
- 文献审查澄清了AD护理的远程监控技术,趋势和研究缺口.
- 新型策略对于改善患者的治疗结果和减少护理人员/专业人员负担具有重要意义.
- 一项拟议的框架旨在指导高级AD护理的跨学科研究.
相关概念视频
01:29Documentation in Long-Term and Home Healthcare Setting
835
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
835
01:26Alzheimer's Disease: Overview
342
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
342
01:22Alzheimer's Disease: Treatment
133
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
133